Terms: = Endocrine gland cancer AND HIF1A, Q16665, 3091, ENSG00000100644, MOP1, HIF1-ALPHA, PASD8, HIF-1alpha AND Treatment
230 results:
1. MKLN1-AS promotes pancreatic cancer progression as a crucial downstream mediator of HIF-1α through miR-185-5p/TEAD1 pathway.
Chen J; Li L; Feng Y; Zhao Y; Sun F; Zhou X; Yiqi D; Li Z; Kong F; Kong X
Cell Biol Toxicol; 2024 May; 40(1):30. PubMed ID: 38740637
[TBL] [Abstract] [Full Text] [Related]
2. OTUB2 silencing promotes ovarian cancer via mitochondrial metabolic reprogramming and can be synthetically targeted by CA9 inhibition.
Nan Y; Wu X; Luo Q; Chang W; Zhao P; Zhang L; Liu Z
Proc Natl Acad Sci U S A; 2024 May; 121(19):e2315348121. PubMed ID: 38701117
[TBL] [Abstract] [Full Text] [Related]
3. Identification of core genes of craniopharyngioma angiogenesis based on single-cell nuclear transcriptome sequencing.
Zhang J; Xu L; Ye J; Xu C; Wu B; Wu J; Hong T
Cell Mol Biol (Noisy-le-grand); 2024 Mar; 70(3):136-141. PubMed ID: 38650143
[TBL] [Abstract] [Full Text] [Related]
4. CXXC5 drove inflammation and ovarian cancer proliferation via transcriptional activation of ZNF143 and EGR1.
Geng T; Sun Q; He J; Chen Y; Cheng W; Shen J; Liu B; Zhang M; Wang S; Asan K; Song M; Gao Q; Song Y; Liu R; Liu X; Ding Y; Jing A; Ye X; Ren H; Zeng K; Zhou Y; Zhang B; Ma S; Liu W; Liu S; Ji J
Cell Signal; 2024 Jul; 119():111180. PubMed ID: 38642782
[TBL] [Abstract] [Full Text] [Related]
5. Calix[6]arene dismantles extracellular vesicle biogenesis and metalloproteinases that support pancreatic cancer hallmarks.
Cordeiro HG; Azevedo-Martins JM; Faria AVS; Rocha-Brito KJP; Milani R; Peppelenbosch M; Fuhler G; de Fátima Â; Ferreira-Halder CV
Cell Signal; 2024 Jul; 119():111174. PubMed ID: 38604340
[TBL] [Abstract] [Full Text] [Related]
6. NNT-AS1 in CAFs-derived exosomes promotes progression and glucose metabolism through miR-889-3p/HIF-1α in pancreatic adenocarcinoma.
Zhang P; Wang Q; Lu W; Zhang F; Wu D; Sun J
Sci Rep; 2024 Mar; 14(1):6979. PubMed ID: 38521881
[TBL] [Abstract] [Full Text] [Related]
7. cancer-associated fibroblast-secreted FGF7 as an ovarian cancer progression promoter.
Feng S; Ding B; Dai Z; Yin H; Ding Y; Liu S; Zhang K; Lin H; Xiao Z; Shen Y
J Transl Med; 2024 Mar; 22(1):280. PubMed ID: 38491511
[TBL] [Abstract] [Full Text] [Related]
8. Essential role of PLD2 in hypoxia-induced stemness and therapy resistance in ovarian tumors.
Muñoz-Galván S; Verdugo-Sivianes EM; Santos-Pereira JM; Estevez-García P; Carnero A
J Exp Clin Cancer Res; 2024 Feb; 43(1):57. PubMed ID: 38403587
[TBL] [Abstract] [Full Text] [Related]
9. ALDH1A3 contributes to tumorigenesis in high-grade serous ovarian cancer by epigenetic modification.
Huang J; Tang Y; Li Y; Wei W; Kang F; Tan S; Lin L; Lu X; Wei H; Wang N
Cell Signal; 2024 Apr; 116():111044. PubMed ID: 38211842
[TBL] [Abstract] [Full Text] [Related]
10. Research progress on the mechanism of glycolysis in ovarian cancer.
Li C; Liu FY; Shen Y; Tian Y; Han FJ
Front Immunol; 2023; 14():1284853. PubMed ID: 38090580
[TBL] [Abstract] [Full Text] [Related]
11. Asiaticoside Down-Regulates HIF-1α to Inhibit Proliferation, Migration, and Angiogenesis in Thyroid cancer Cells.
Zhang Y; Han Y; Dong J; Li F; Sun Y
Balkan Med J; 2024 Jan; 41(1):23-29. PubMed ID: 38044598
[TBL] [Abstract] [Full Text] [Related]
12. Hypoxia mediates immune escape of pancreatic cancer cells by affecting miR-1275/AXIN2 in natural killer cells.
Ou Z; Lu Y; Xu D; Luo Z
Front Immunol; 2023; 14():1271603. PubMed ID: 38035113
[TBL] [Abstract] [Full Text] [Related]
13. Hypoxia promotes the growth and metastasis of ovarian cancer cells by suppressing ferroptosis via upregulating SLC2A12.
Li M; Li L; Cheng X; Li L; Tu K
Exp Cell Res; 2023 Dec; 433(2):113851. PubMed ID: 37940066
[TBL] [Abstract] [Full Text] [Related]
14. Cytotoxic effects of Phenformin on ovarian cancer cells: expression of HIF-1α and PDK1 in the hypoxic microenvironment.
Gunaydin B; Yigitturk G; Elbe H
Rom J Morphol Embryol; 2023; 64(3):355-361. PubMed ID: 37867353
[TBL] [Abstract] [Full Text] [Related]
15. HIF-1α regulates the cell viability in radioiodine-resistant papillary thyroid carcinoma cells induced by hypoxia through PKM2/NF-κB signaling pathway.
Wang D; Liu X; Li M; Ning J
Mol Carcinog; 2024 Feb; 63(2):238-252. PubMed ID: 37861358
[TBL] [Abstract] [Full Text] [Related]
16. PNU-74654 Induces Cell Cycle Arrest and Inhibits EMT Progression in Pancreatic cancer.
Chien TL; Wu YC; Lee HL; Sung WW; Yu CY; Chang YC; Lin CC; Wang CC; Tsai MC
Medicina (Kaunas); 2023 Aug; 59(9):. PubMed ID: 37763649
[No Abstract] [Full Text] [Related]
17. Stem cell factor modulates HIF-1α levels and diminishes 5-FU sensitivity in 5-FU resistant pancreatic cells by altering the anabolic glucose metabolism.
Xiang F; Luo F
J Biochem Mol Toxicol; 2023 Dec; 37(12):e23487. PubMed ID: 37718545
[TBL] [Abstract] [Full Text] [Related]
18. Clinicopathological correlations of endometrioid and clear cell carcinomas in the uterus and ovary.
Mori H; Nishida H; Kusaba T; Kawamura K; Oyama Y; Daa T
Medicine (Baltimore); 2023 Sep; 102(37):e35301. PubMed ID: 37713813
[TBL] [Abstract] [Full Text] [Related]
19. Reduced expression of phosphorylated ataxia-telangiectasia mutated gene is related to poor prognosis and gemcitabine chemoresistance in pancreatic cancer.
Xun J; Ohtsuka H; Hirose K; Douchi D; Nakayama S; Ishida M; Miura T; Ariake K; Mizuma M; Nakagawa K; Morikawa T; Furukawa T; Unno M
BMC Cancer; 2023 Sep; 23(1):835. PubMed ID: 37674118
[TBL] [Abstract] [Full Text] [Related]
20. Hypoxia-induced PPFIA4 accelerates the progression of ovarian cancer through glucose metabolic reprogramming.
Tan S; Yu H; Xu Y; Zhao Y; Lou G
Med Oncol; 2023 Aug; 40(9):272. PubMed ID: 37596446
[TBL] [Abstract] [Full Text] [Related]
[Next]
